Treatment effect estimation using the propensity score in clinical trials with historical control
Abstract Background Clinical trials assessing new treatment effects require a control group to compare the pure treatment effects. However, in clinical trials on regenerative medicine, rare diseases, and intractable diseases, it may be ethically difficult to assign participants to the control group....
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMC
2024-02-01
|
| Sarja: | BMC Medical Research Methodology |
| Aiheet: | |
| Linkit: | https://doi.org/10.1186/s12874-023-02127-9 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|